Raymond James Financial Services Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $447K | Buy |
|
|||||
|
2024
Q2 | $554K | Buy |
|
|||||
|
2024
Q1 | $665K | Buy |
|
|||||
|
2023
Q4 | $589K | Sell |
|
|||||
|
2023
Q3 | $460K | Sell |
|
|||||
|
2023
Q2 | $1.19M | Buy |
|
|||||
|
2023
Q1 | $753K | Sell |
|
|||||
|
2022
Q4 | $590K | Sell |
|
|||||
|
2022
Q3 | $798K | Sell |
|
|||||
|
2022
Q2 | $604K | Sell |
|
|||||
|
2022
Q1 | $746K | Sell |
|
|||||
|
2021
Q4 | $1.23M | Buy |
|
|||||
|
2021
Q3 | $532K | Buy |
|
|||||
|
2021
Q2 | $848K | Sell |
|
|||||
|
2021
Q1 | $1.1M | Buy |
|
|||||
|
2020
Q4 | $1.33M | Buy |
|
|||||
|
2020
Q3 | $297K | Buy |
|
|||||
|
2020
Q2 | $268K | Buy |
|